Liver stiffness measurement for risk assessment of hepatocellular carcinoma
Hepatology Research2014Vol. 45(5), pp. 523–532
Citations Over TimeTop 16% of 2014 papers
Akihisa Tatsumi, Shinya Maekawa, Mitsuaki Sato, Nobutoshi Komatsu, Mika Miura, Fumitake Amemiya, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto, Nobuyuki Enomoto
Abstract
Liver stiffness cut-off values and their association with HCC concurrence were different depending on the etiology. In HCV, liver stiffness of more than 12.0 kPa was an independent risk factor for new HCC development. Collectively, determining the fibrotic cut-off values for HCC concurrence would be important in evaluating HCC risks.
Related Papers
- → Hepatitis B Virus-Associated Hepatocellular Carcinoma(2022)191 cited
- Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma.(2003)
- → Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India(1992)34 cited
- → Risk Factors of Hepatocellular Carcinoma in Chronic Hepatitis C and Cirrhosis: Special Reference to Laparoscopic Findings(1999)2 cited
- → Expression of three common serum enzymes in patients with hepatitis B related hepatocellular carcinoma(2019)